Emergence of Carbapenem-Resistant Klebsiella pneumoniae in a Romanian Infectious Diseases Hospital
Pathogens · 29.08.2025 · 14 (9) · 859
DOI: 10.3390/pathogens14090859 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, online erschienen am 29.08.2025. Verfasst von Dragos Stefan Lazar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Klebsiella Infections, Carbapenems, Drug Resistance, Multiple, Bacterial. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Klebsiella pneumoniae, a member of the Enterobacterales Order, often colonises the gut and causes diverse infections, including bloodstream, urinary, and respiratory infections. The rise in carbapenem-resistant sFtrains, especially those producing enzymes like K. pneumoniae carbapenemase (KPC), New Delhi metallo-β-lactamase (NDM), Oxacillinase 48 (OXA48), or combinations (NDM+OXA48-like), poses a significant threat across Europe, notably in Romania. These strains spread rapidly via mobile genetic elements, complicating treatment.
Methods
A retrospective study of multidrug-resistant (MDR) K. pneumoniae strains isolated from clinical samples collected at an infectious diseases hospital in Romania.
Results
We analysed the evolution of carbapenemases and their combinations from 2010 to 2024, with the rising antibiotic consumption, particularly during the COVID-19 pandemic. The prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) rose from 4.9% in 2010 to 41.6% in 2024. There was an overall antibiotic use increase, especially colistin (186%) between 2019–2024. Additionally, we examined the dynamics of antibiotic susceptibility that decreased in 2023–2024 and found that susceptibility of NDM+OXA48-like isolates to colistin was 16.5% and to cefiderocol 58.5%.
Conclusions
The rising prevalence of K. pneumoniae strains with complex resistance mechanisms, coupled with a significant reduction in available treatment options, demands a fundamental paradigm shift in the management of these infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- "Dr Victor Babes" Clinical Hospital of Infectious and Tropical Diseases, 030303 Bucharest, Romania.
ORCID-Profile: Simin Aysel Florescu, George Sebastian Gherlan
Zitieren
APA
Lazar, D. S., Nica, M., Oprisan, C., Vlasie, M., Condurache, I. A., Florescu, S. A., & Gherlan, G. S. (2025). Emergence of Carbapenem-Resistant Klebsiella pneumoniae in a Romanian Infectious Diseases Hospital. Pathogens, 14(9), 859. https://doi.org/10.3390/pathogens14090859
Vancouver
Lazar DS, Nica M, Oprisan C, Vlasie M, Condurache IA, Florescu SA, et al. Emergence of Carbapenem-Resistant Klebsiella pneumoniae in a Romanian Infectious Diseases Hospital. Pathogens. 2025;14(9):859. doi:10.3390/pathogens14090859
BibTeX
@article{Lazar2025,
author = {Lazar, Dragos Stefan and Nica, Maria and Oprisan, Corina and Vlasie, Maricela and Condurache, Ilie-Andrei and Florescu, Simin Aysel and Gherlan, George Sebastian},
title = {Emergence of Carbapenem-Resistant Klebsiella pneumoniae in a Romanian Infectious Diseases Hospital},
journal = {Pathogens},
year = {2025},
volume = {14},
number = {9},
pages = {859},
doi = {10.3390/pathogens14090859}
}
EUVIMED